COVID-19 Treatments

Using COVID-19 oral antivirals in practice

15 December 2021Deployment should address a range of factors and be implemented through different mechanisms. Collecting data and learning will support continued safe use.

Getting ready to use sotrovimab: guidance for Chief Pharmacists

14 December 2021This guidance for Chief Pharmacists supports the pharmacy institutional readiness for the management of sotrovimab in COVID-19 infection.

Handling and preparation of sotrovimab

14 December 2021An outline process and supporting materials to help Trusts deploy sotrovimab

Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are pregnant

12 October 2021A careful risk assessment should be done on the benefits of this off-label use to the mother, and the risks it poses to the fetus or neonate.

Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are breastfeeding

12 October 2021Tocilizumab and sarilumab can be used off-label to treat hospitalised patients with COVID-19. Breastfeeding can continue if these treatments are required.

COVID-19 neutralising monoclonal antibodies and SPS support

17 September 2021Implementation of effective process control is essential to ensure that neutralising monoclonal antibody products are implemented safely.

Casirivimab and imdevimab: Guidance for Chief Pharmacists

17 September 2021The SPS guidance on handling casirivimab and imdevimab has now been withdrawn and all stocks have expired

SPS - Specialist Pharmacy Service

NHS